BackAscendis Pharma A/S Overview

Ascendis Pharma A/S Accounts Payable

Latest accounts payable for ASND: $79M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$78.67M
6.76% YoYΔ $-5.70M vs prior year quarter

Peer average

Loading

Ascendis Pharma A/S Accounts Payable History

Loading

Ascendis Pharma A/S vs. peers: Accounts Payable Comparison

Loading

Ascendis Pharma A/S Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ascendis Pharma A/S (ASND) FAQ

As of the most recent data (March 2026), ASND shows a accounts payable of $79M. That compares with $84M in the prior-year period — down 6.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ASND's accounts payable is now $79M (was $84M) — a 6.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ascendis Pharma A/S is outperforming or lagging.

Tracking ASND's accounts payable over time shows whether Ascendis Pharma A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $79M That compares with $84M in the prior-year period — down 6.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Ascendis Pharma A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $79M) with ownership activity and broader fundamentals.

Ascendis Pharma A/S's accounts payable is $79M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.